Inspira Technologies $22.5M purchase order

Inspira Technologies (IINN) has secured a binding $22.5M purchase order for its FDA-cleared ART100 system, representing a major commercial inflection point for the Company. The order was placed by a privately held company headquartered outside the United States, in a global strategic hub, with an established track record and active commercial ties to both government entities and institutional healthcare customers. Under the terms of the binding purchase order, full payment of $22.5M is to be made during 2025. Inspira and the purchasing organization have initiated onboarding, logistics planning, and deployment scheduling, with immediate implementation.